EUVIMEDSkopri EUVIMED
CrossrefKarta ta’ informazzjoni

YouTube Videos as Educational Resources for Seizure Clusters and Treatment Options: Cross-Sectional Observational Study

Taylor S Elliott, Andrew J Gienapp, James W Wheless

JMIR Infodemiology · 2026-09-30 · 6 · e98768-e98768

DOI: 10.2196/98768 ↗
AstrattDettalji biblijografiċi

Astratt

Abstract Background Patients with seizure clusters and their families often use YouTube videos as resources for information about the illness and how to use concomitant rescue medications; however, many videos include misinformation or incorrect information that could potentially cause harm. Objective This study aims to examine YouTube videos intended as educational and instructional resources for seizure clusters and treatment options posted since the approval of intranasal benzodiazepine rescue medications in 2019 and to assess their accuracy and quality using a 3-item rating scale. Methods We searched YouTube for 10 specific terms related to seizure clusters and treatment options and analyzed videos from the first 20 results for each to mimic internet user behavior when choosing results with search engines. Videos were rated on 3 criteria: accurate seizure cluster definition, appropriate US Food and Drug Administration (FDA)–approved treatment recommendation, and correct visual demonstration of rescue medication use. A single author rated the videos based on the presence of specific subcriteria of all 3 primary criteria in each video. Score assignment was based on the number of present subcriteria. Results Seizure clusters and trade names generated the highest number of videos meeting criteria; other search terms, including nonproprietary names, garnered

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.

Ara t-tariffi →